Noticias Celltex
NFL legends travel to Cancun to participate in stem cell clinical trial to alleviate sports injuries
Football legends and Celltex clients Jackie Sherrill, Bob Lilly, Lee Roy Jordan and Mel Renfro recently traveled to Hospital Galenia in Cancun, Mexico to receive stem cell therapy as part of Celltex’s Rheumatoid Arthritis and Osteoarthritis protocol clinical trial authorized by COFEPRIS, Mexico’s regulatory governing body equivalent to the US Federal Drug Administration (FDA).
Celltex’s proprietary technology of isolating, multiplying and banking autologous (one’s own) adult mesenchymal stem cells (MSCs) for therapeutic use has been recognized in the world of professional sports for helping athletes improve their quality of life by alleviating pain from longtime careers on the field.
Thanks to stem cell therapy using his own stem cells produced by Celltex, Sherrill was able to avoid a double knee replacement and a rotator cuff repair. Lilly regained full range of motion in his shoulders and Jordan experienced increased energy levels and enhanced cognitive functioning after receiving stem cell therapy.
Sherill has dedicated his post-football career to working with Celltex on advancing stem cell therapy research awareness, through visits such as the recent trip to Hospital Galenia, to help improve quality of life for other professional athletes. He hopes to continue bringing awareness about the safety and efficacy of adult stem cell therapy to professional sports leagues. In 2018, Sherrill co-founded the Institute for Stem Cell Research and Education (ISCRE) with a mission to help former athletes, servicemen/women and Alzheimer patients improve the quality of their lives through the advancement of stem cell technology by education, research and new clinical applications.
Celltex looks forward to progressing with their clinical trial, in hopes that one day, millions of Americans in need will be able to access the regenerative power of their own adult stem cells for therapeutic purposes.
Noticias más recientes
Desarrollo de terapias COVID-19 a partir de tejidos de parto y sangre del cordón
Celltex Therapeutics Corporation se mencionó en la publicación Stem Cell Journals como uno de los cinco ensayos de terapia con células madre más grandes que utilizan MSC para combatir el COVID en un artículo titulado “Desarrollo de terapias COVID-19 a partir de tejidos de parto y sangre del cordón umbilical”.
Leer másCompañía de Houston obtiene luz verde para estudiar sus propias células madre para prevenir COVID-19
Noticias prometedoras de Houston de una empresa que obtuvo la autorización de la FDA para intentar usar las propias células madre de una persona para prevenir el COVID-19. Celltex Therapeutics Corporation también espera que las células madre ayuden a tratar algunos de los casos más graves.
Leer más